MYD88 L265P mutation in primary central nervous system lymphoma is associated with better survival: A single-center experience

BACKGROUND: The myeloid differentiation primary response gene (MYD88) mutation in primary central nervous system lymphomas (PCNSL) may be associated with unfavorable prognosis; however, current evidence remains limited. We aimed to characterize PCNSLs by integration of clinicopathological, molecular...

Descripción completa

Detalles Bibliográficos
Autores principales: Curran, Olimpia E, Poon, Michael T C, Gilroy, Louise, Torgersen, Antonia, Smith, Colin, Al-Qsous, Wael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349182/
https://www.ncbi.nlm.nih.gov/pubmed/34377990
http://dx.doi.org/10.1093/noajnl/vdab090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349182/
https://www.ncbi.nlm.nih.gov/pubmed/34377990
http://dx.doi.org/10.1093/noajnl/vdab090

Ejemplares similares